Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · IEX Real-Time Price · USD
29.46
+0.50 (1.73%)
At close: Jul 19, 2024, 4:00 PM
29.35
-0.11 (-0.37%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

Q32 Bio Revenue

Q32 Bio had revenue of $354.00K in the twelve months ending March 31, 2024. In the year 2023, Q32 Bio had annual revenue of $1.16M.

Revenue (ttm)
$354.00K
Revenue Growth
-93.39%
P/S Ratio
993.83
Revenue / Employee
$9,568
Employees
37
Market Cap
351.81M

Revenue Chart

* The company reports in USD currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.16M-2.05M-63.97%
Dec 31, 20223.21M-30.76M-90.56%
Dec 31, 202133.97M31.27M1,157.25%
Dec 31, 20202.70M1.04M62.18%
Dec 31, 20191.67M-3.66M-68.70%
Dec 31, 20185.32M--
Dec 31, 20170--
Dec 31, 20160--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
ModivCare 2.78B
Vanda Pharmaceuticals 177.60M
Xeris Biopharma Holdings 171.36M
Talkspace 162.13M
Cartesian Therapeutics 25.91M
uniQure 19.00M
AC Immune 16.82M
TScan Therapeutics 14.81M
Revenue Rankings